Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Orionis Biosciences

Orionis Biosciences?uq=PEM9b6PF
2015 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$19.7M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of precision drugs and medical equipment designed to focus on new strategies to combat cancer. The company's drugs and equipment are tested various times on animals before human application, enabling patients to get assurance on the quality of medicines and get advanced treatment.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Devices and Supplies
Biotechnology
Primary Office
  • 275 Grove Street
  • Building 2, 4th Floor
  • Newton, MA 02466
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Orionis Biosciences’s full profile, request a free trial.

Orionis Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 03-Apr-2018 $19.7M 000.00 Completed Product Development
2. Convertible Debt 30-Jan-2017 00000 00.000 Completed Startup
1. Early Stage VC 13-Apr-2016 $6M $6M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Orionis Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Empire Angels Angel Group Minority 000 0000 000000 0
Excel Venture Management Venture Capital Minority 000 0000 000000 0
SeedStep Angels Angel Group Minority 000 0000 000000 0
V-Bio Ventures Venture Capital Minority 000 0000 000000 0

Orionis Biosciences Executive Team (2)

Name Title Board
Seat
Contact
Info
Nikolai Kley Ph.D Chief Executive Officer, President, Board Member, Manager & Co-Founder
Jan Tavernier Chief Technology Officer & Co-Founder

Orionis Biosciences Board Members (3)

Name Representing Role Since Contact
Info
Griet Vanpoucke Self Board Member 000 0000
Nikolai Kley Ph.D Orionis Biosciences Chief Executive Officer, President, Board Member, Manager & Co-Founder 000 0000
Steve Gullans Ph.D Excel Venture Management Board Member 000 0000